Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer

Vanessa Wong, Richard de Boer, Sally Baron‐Hay, Robert Blum, Frances Boyle, Susan Chua, Kerrie Clarke, Katharine Cuff, Michael Green, Elgene Lim, Kelly Mok, Louise Nott, Michelle Nottage, Ali Tafreshi, Daphne Tsoi, Anthony Uccellini, Wei Hong, Peter Gibbs, Sheau Wen Lok